FindTrial
Sign In

To look for any improvement or decline of a patients status after undergoing surgical removal of thymus by the use of instruments designed to be used through small incisions made on chest.

Neurological outcomes following minimally invasive thymectomy in Non-Thymomatous Myasthenia Gravis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/06/025612
Enrollment
151
Registered
2020-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G700- Myasthenia gravis

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

All India Institute of Medical Sciences New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Non-Thymomatous Myasthenia Gravis Patients whose disease is well controlled on medications

Exclusion criteria

Exclusion criteria: Patients with Non-Thymomatous Myasthenia Gravis not willing to give consent to participate in this study Patients with Non-Thymomatous Myasthenia Gravis not fit for General Anesthesia.

Design outcomes

Primary

MeasureTime frame
Primary:To assess the mid and long term neurological outcomes in non thymomatous myasthenia gravis following minimally invasive surgery.Timepoint: At 6 monthly intervals post surgery till completion of thesis—

Secondary

MeasureTime frame
To assess the quality of life of patients after thymectomy by the use of MG-QOL15r and MG-ADL asssessment scales.Timepoint: At 6 monthly intervals post surgery till completion of thesis—

Countries

India

Contacts

Public ContactJaidev G

All India Institute of Medical Sciences, New Delhi

rajinder.parshad@gmail.com9810359760

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026